LISATA THERAPEUTICS, INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Lisata Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q4 2024.
  • Lisata Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $339K, a 48.6% decline year-over-year.
  • Lisata Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $1.63M, a 35.9% decline year-over-year.
  • Lisata Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was $1.63M, a 35.9% decline from 2023.
  • Lisata Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $2.54M, a 183% increase from 2022.
  • Lisata Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $897K, a 1080% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $1.63M $339K -$321K -48.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 $1.95M $406K -$297K -42.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $2.24M $479K -$39K -7.53% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.28M $402K -$255K -38.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $2.54M $660K +$109K +19.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 $2.43M $703K +$366K +109% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.06M $518K +$424K +451% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $1.64M $657K +$742K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $897K $551K +$496K +902% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $401K $337K +$296K +722% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $105K $94K +$137K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$32K -$85K -$108K -470% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $76K $55K +$41K +293% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $35K $41K +$16K +64% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $19K -$43K -$65K -295% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $84K $23K -$48K -67.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $132K $14K -$115K -89.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 $247K $25K -$150K -85.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $397K $22K -$187K -89.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $584K $71K -$156K -68.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $740K $129K -$109K -45.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $849K $175K -$39K -18.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $888K $209K +$17K +8.85% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $871K $227K +$52K +29.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $819K $238K +$108K +83.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $711K $214K +$45.8K +27.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $665K $192K +$392K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $273K $175K +$378K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$105K $130K +$274K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 -$379K $168K +$531K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$911K -$200K +$127K +39% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$1.04M -$203K +$718K +77.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$1.76M -$144K -$13M -101% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 $11.2M -$363K +$600K +62.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $10.6M -$327K -$5.13M -107% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $15.8M -$921K +$176K +16% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $15.6M $12.8M +$9.23M +255% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 $6.36M -$963K -$92.5K -10.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $6.46M $4.81M +$5.1M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $1.36M -$1.1M -$813K -287% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 $2.17M $3.62M +$5.55M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$3.38M -$871K -$952K -1175% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$2.43M -$292K -$284K -3594% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$2.15M -$284K -$251K -761% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$1.9M -$1.94M +$2.63M +57.6% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 -$4.53M $81K +$540K Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 -$5.07M -$7.89K +$419K +98.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$5.49M -$33K +$404K +92.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$5.89M -$4.57M -$4.6M -14836% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 -$1.29M -$459K -$1.12M -170% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$172K -$427K -$276K -184% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $104K -$437K +$666K +60.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$562K $31K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 $660K +$625K +1777% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$150K -$294K -205% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q3 2010 $35.2K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $143K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.